U.S. Food, 2006: The 2006 FDA Public Health Advisory on methemoglobinemia from benzocaine sprays used in procedures in the mouth and throat.
Benzocaine sprays used in the mouth and throat can result in potentially dangerous levels of methemoglobinemia.
U.S. Food, 2006: The 2006 FDA Public Health Advisory on methemoglobinemia from benzocaine sprays used in procedures in the mouth and throat. C2. The archived page carries no printed issue date; it is dated 2006 because it reports the February 8, 2006 Veterans Health Administration decision to stop using benzocaine sprays and because the 2011 spray communication refers back to it as the 2006 advisory (MTI-11). Date recorded as year only; access date 2026-11-21, page undated. The advisory notes FDA was 'not planning action to remove the drugs from the market' at that time and lists higher-risk groups (children under 4 months, G6PD deficiency, hemoglobin-M disease, NADH-methemoglobin reductase deficiency, pyruvate-kinase deficiency). Study type: regulatory record.
